Insulin pump treatment of childhood type 1 diabetes.
Pediatr Clin North Am
; 52(6): 1677-88, 2005 Dec.
Article
em En
| MEDLINE
| ID: mdl-16301088
ABSTRACT
Current goals for the treatment of children and adolescents with type 1 diabetes mellitus include achieving near-normal blood sugar levels, minimizing the risk of hypoglycemia, optimizing quality of life, and preventing or delaying long-term microvascular complications. Continuous subcutaneous insulin infusion (CSII) provides a treatment option that can assist in the attainment of all of these goals in all ages of children. Usage of CSII has been demonstrated to reduce glycosylated hemoglobin levels and frequency of severe hypoglycemia, without sacrifices in safety, quality of life, or weight gain, particularly in conjunction with the use of new insulin analogs and improvements in pump technology. Clinical studies of safety and efficacy of CSII in children are reviewed.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 1
/
Insulina
Tipo de estudo:
Clinical_trials
Aspecto:
Patient_preference
Limite:
Child
/
Humans
Idioma:
En
Revista:
Pediatr Clin North Am
Ano de publicação:
2005
Tipo de documento:
Article